Physician

Charles C Reel, M.D.

According to 2025 Medicare claims, Charles Reel, M.D. (NPI: 1619973773) practices neurology in the Lexington Park, MD market, with the plurality of this provider's patient population coming from St. Marys, MD. This provider's primary affiliated billing organization is CHARLES C REEL, M.D. (NPI: 1902094188) and primary practice location at 20622-3196.

Reel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 455 traditional Medicare patients, billed 5,073 HCPCS/CPT codes, and received $294,057 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 198 prescription claims across 77 beneficiaries totaling $14,829 in drug costs, led by Carbidopa-Levodopa Er (Carbidopa/Levodopa). DME data shows 12 claims. Open Payments data shows 1 records totaling $26. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $25,645 to $14,829. In contrast, DME billing represents a smaller volume and declined steadily, from $14,910 to $2,921.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	440	2,946	$225,457
2016	479	3,116	$226,230
2017	508	3,162	$231,413
2018	494	3,315	$237,405
2019	498	5,096	$301,884
2020	465	3,900	$267,197
2021	430	4,036	$272,736
2022	430	4,770	$302,465
2023	432	4,973	$287,042
2024	455	5,073	$294,057

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	48	193	$25,645
2016	58	242	$27,769
2017	52	242	$108,389
2018	54	168	$140,046
2019	46	160	$102,582
2020	46	101	$53,369
2021	49	127	$7,464
2022	46	98	$10,706
2023	52	134	$33,501
2024	77	198	$14,829

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	93	$2,986
2016	11	104	$2,915
2017	41	196	$5,031
2018	56	230	$4,989
2019	33	183	$4,229
2020	11	127	$4,061
2021	40	124	$3,864
2022	N/R	35	$1,210
2023	N/R	50	$1,258
2024	N/R	12	$148

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	219	288	$136
95923	Testing of autonomic (sympathetic) nervous system function	157	158	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	264	461	$90
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	160	414	$76
95921	Testing of autonomic nervous system function and heart rate response to deep breathing	157	158	$67

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	995	$855
Gabapentin	Gabapentin	39	2,827	$549
Propranolol Hcl Er	Propranolol Hcl	13	497	$471
Carbidopa-Levodopa	Carbidopa/Levodopa	18	1,320	$416
Memantine Hcl	Memantine Hcl	17	990	$357

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	12	$148

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$26	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles C. Reel, M.D.?

Tedicare shows public-source Medicare data for Charles C. Reel, M.D. (NPI 1619973773), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles C. Reel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles C. Reel, M.D.?

Charles C. Reel, M.D. is linked to CHARLES C REEL, M.D. (billing NPI 1902094188) in the available physician profile data.

Does Charles C. Reel, M.D. have Open Payments data?

Charles C. Reel, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.